Violation Tracker Parent Company Summary
Parent Company Name:
Boehringer Ingelheim
Ownership Structure:
privately held
Headquartered in:
Germany
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$138,001,089
Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
healthcare-related offenses | $108,500,000 | 3 |
government-contracting-related offenses | $29,057,000 | 7 |
employment-related offenses | $429,089 | 2 |
safety-related offenses | $15,000 | 1 |
Top 5 Primary Offense Types | Penalty Total | Number of Records |
off-label or unapproved promotion of medical products | $108,500,000 | 3 |
False Claims Act and related | $29,057,000 | 7 |
employment discrimination | $379,089 | 1 |
labor relations violation | $50,000 | 1 |
aviation safety violation | $15,000 | 1 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Associated Names:
Boehringer Ingelheim Animal Health USA Inc.; Boehringer Ingelheim Corp.; BOEHRINGER INGELHEIM PHARMACEUTICAL; Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc.; Boehringer Ingelheim Roxane, Inc. et al.; Boehringer Ingleheim
Links:
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
Download results as 
or
XML (maximum 10,000; for access to larger downloads contact
Phil Mattera)
Company |
Primary Offense Type |
Year |
Agency |
Penalty Amount |
Boehringer Ingelheim Pharmaceuticals Inc. |
off-label or unapproved promotion of medical products |
2012 |
FDA |
$95,000,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. |
off-label or unapproved promotion of medical products |
2012 |
MULTI-AG |
(*) $95,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
off-label or unapproved promotion of medical products |
2017 |
MULTI-AG |
$13,500,000 |
Boehringer Ingelheim Corp. |
False Claims Act and related |
2005 |
TX-AG |
$10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
False Claims Act and related |
2010 |
WI-AG |
$7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. |
False Claims Act and related |
2009 |
KY-AG |
$4,500,000 |
Boehringer Ingelheim |
False Claims Act and related |
2012 |
LA-AG |
$3,250,000 |
Boehringer Ingelheim Roxane, Inc. |
False Claims Act and related |
2008 |
MA-AG |
$1,800,000 |
Boehringer Ingleheim |
False Claims Act and related |
2011 |
KS-AG |
$1,400,000 |
Boehringer Ingelheim Animal Health USA Inc. |
employment discrimination |
2020 |
OFCCP |
$379,089 |
Boehringer Ingelheim Roxane, Inc. et al. |
False Claims Act and related |
2009 |
IA-AG |
$357,000 |
Boehringer Ingelheim Pharmaceutical, Inc. |
labor relations violation |
2004 |
NLRB |
$50,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS |
aviation safety violation |
2014 |
FAA |
$15,000 |
Download results as 
or
XML (maximum 10,000; for access to larger downloads contact
Phil Mattera)